Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025Fast Track ...

A research team led by Professor Takuya Yamamoto and Assistant Professor Ryusaku Matsumoto (Department of Life Science ...

The field of plasma cell disorders has advanced primarily because of the collective efforts of members in cooperative ...

A National Transportation Safety Board (NTSB) report indicates that the tractor-trailer driver involved in a fatal July 2024 crash on Interstate 95 was using his cell phone at the time. Five people ...

A cell therapy preserves muscle structure and function in laboratory mice with a type of disease similar to Duchenne muscular ...

The human genome consists of 3 billion base pairs, and when a cell divides, it takes about seven hours to complete making a ...

According to a post from the department's Facebook profile, responders arrived at the Verizon Wireless store, located at ...

Three years ago, Daniel Cressy discovered his love of flying. But after hours of lessons, working toward his certification, ...

From the moment the disgraced financier’s body was discovered hanging by a noose around his neck from a lower bunk bed in the ...

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine.